Acetaminophen is the active ingredient in Tylenol and hundreds of over-the-counter and prescription medicines. It is commonly prescribed during pregnancy to relieve pain and fever.
This is the first study to examine language development in relation to acetaminophen levels in urine.
Information was gathered from 754 women who were enrolled into the study in weeks 8-13 of their pregnancy.
Researchers at Icahn School of Medicine at Mount Sinai in the US asked participants to report the number of acetaminophen tablets they had taken between conception and enrolment, and tested the acetaminophen concentration in their urine at enrolment.
Acetaminophen was used by 59 per cent of the women in early pregnancy, according to the study published in the journal European Psychiatry.
Acetaminophen use was quantified in two ways: High use vs no use analysis used women who did not report any use as the comparison group. For the urine analysis, the top quartile of exposure was compared to the lowest quartile.
However, girls born to mothers with higher exposure - those who took acetaminophen more than six times in early pregnancy - were nearly six times more likely to have language delay than girls born to mothers who did not take acetaminophen.
These results are consistent with studies reporting decreased IQ and increased communication problems in children born to mothers who used more acetaminophen during pregnancy.
Both the number of tablets and concentration in urine were associated with a significant increase in language delay in girls, and a slight but not significant decrease in boys.
"Given the prevalence of prenatal acetaminophen use and the importance of language development, our findings, if replicated, suggest that pregnant women should limit their use of this analgesic during pregnancy," said Shanna Swan, from the Icahn School of Medicine at Mount Sinai.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
